BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24476585)

  • 1. The fluorescent two-hybrid assay to screen for protein-protein interaction inhibitors in live cells: targeting the interaction of p53 with Mdm2 and Mdm4.
    Yurlova L; Derks M; Buchfellner A; Hickson I; Janssen M; Morrison D; Stansfield I; Brown CJ; Ghadessy FJ; Lane DP; Rothbauer U; Zolghadr K; Krausz E
    J Biomol Screen; 2014 Apr; 19(4):516-25. PubMed ID: 24476585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53.
    Wong JH; Alfatah M; Sin MF; Sim HM; Verma CS; Lane DP; Arumugam P
    BMC Biol; 2017 Nov; 15(1):108. PubMed ID: 29121928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the MDM2/MDM4 interaction interface as a promising approach for p53 reactivation therapy.
    Pellegrino M; Mancini F; Lucà R; Coletti A; Giacchè N; Manni I; Arisi I; Florenzano F; Teveroni E; Buttarelli M; Fici L; Brandi R; Bruno T; Fanciulli M; D'Onofrio M; Piaggio G; Pellicciari R; Pontecorvi A; Marine JC; Macchiarulo A; Moretti F
    Cancer Res; 2015 Nov; 75(21):4560-72. PubMed ID: 26359458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.
    Dudgeon DD; Shinde S; Hua Y; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
    J Biomol Screen; 2010 Aug; 15(7):766-82. PubMed ID: 20639499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors.
    Espadinha M; Lopes EA; Marques V; Amaral JD; Dos Santos DJVA; Mori M; Daniele S; Piccarducci R; Zappelli E; Martini C; Rodrigues CMP; Santos MMM
    Eur J Med Chem; 2022 Nov; 241():114637. PubMed ID: 35961068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-based high-throughput assay for the screening of small-molecule inhibitors of p53-MDM2 interaction.
    Li J; Zhang S; Gao L; Chen Y; Xie X
    J Biomol Screen; 2011 Apr; 16(4):450-6. PubMed ID: 21471462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53-Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans.
    Coffill CR; Lee AP; Siau JW; Chee SM; Joseph TL; Tan YS; Madhumalar A; Tay BH; Brenner S; Verma CS; Ghadessy FJ; Venkatesh B; Lane DP
    Genes Dev; 2016 Feb; 30(3):281-92. PubMed ID: 26798135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions.
    Lundholt BK; Heydorn A; Bjørn SP; Praestegaard M
    Assay Drug Dev Technol; 2006 Dec; 4(6):679-88. PubMed ID: 17199506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.
    Li Z; Day CP; Yang JY; Tsai WB; Lozano G; Shih HM; Hung MC
    Cancer Res; 2004 Dec; 64(24):9080-5. PubMed ID: 15604276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci.
    Frosi Y; Inoue K; Ramlan SR; Lane DP; Watanabe T; Brown CJ
    Sci Rep; 2019 Nov; 9(1):17933. PubMed ID: 31784573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
    Dudgeon DD; Shinde SN; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
    Assay Drug Dev Technol; 2010 Aug; 8(4):437-58. PubMed ID: 20662736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: identification of novel peptidic inhibitors.
    Noguchi T; Oishi S; Honda K; Kondoh Y; Saito T; Kubo T; Kaneda M; Ohno H; Osada H; Fujii N
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3802-5. PubMed ID: 23726030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays.
    Tan BX; Brown CJ; Ferrer FJ; Yuen TY; Quah ST; Chan BH; Jansson AE; Teo HL; Nordlund P; Lane DP
    Sci Rep; 2015 Jul; 5():12116. PubMed ID: 26159518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stapled peptides with improved potency and specificity that activate p53.
    Brown CJ; Quah ST; Jong J; Goh AM; Chiam PC; Khoo KH; Choong ML; Lee MA; Yurlova L; Zolghadr K; Joseph TL; Verma CS; Lane DP
    ACS Chem Biol; 2013 Mar; 8(3):506-12. PubMed ID: 23214419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Application of Fit Quality to Screen MDM2/p53 Protein-Protein Interaction Inhibitors.
    Xue X; Bao G; Zhang HQ; Zhao NY; Sun Y; Zhang Y; Wang XL
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30513790
    [No Abstract]   [Full Text] [Related]  

  • 16. Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2/MDMX interactions.
    Barakat K; Mane J; Friesen D; Tuszynski J
    J Mol Graph Model; 2010 Feb; 28(6):555-68. PubMed ID: 20056466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using BRET to study chemical compound-induced disruptions of the p53-HDM2 interactions in live cells.
    Mazars A; Fåhraeus R
    Biotechnol J; 2010 Apr; 5(4):377-84. PubMed ID: 20235143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review.
    Teveroni E; Lucà R; Pellegrino M; Ciolli G; Pontecorvi A; Moretti F
    Expert Opin Ther Pat; 2016 Dec; 26(12):1417-1429. PubMed ID: 27603098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
    Zhang W; Zhong T; Chen Y
    J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.
    Sirous H; Chemi G; Campiani G; Brogi S
    Comput Biol Chem; 2019 Dec; 83():107105. PubMed ID: 31473433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.